2009년 인플루엔자 대유행 중 인플루엔자 진료소 방문자의 연령 분포 변화 = Trend in Age Distribution of Visitors to Flu-clinics during the Pandemic Influenza (H1N1 2009)

다국어 초록 (Multilingual Abstract)

The pandemic influenza (H1N1 2009) virus, after being introduced in Korea in April, 2009, spread rapidly nationwide in mid-2009. This study was conducted to characterize trend in age distribution of visitors to Flu-clinics during the pandemic.
Demographic, clinical and laboratory data of visitors to flu clinic from Week 36to 52 (August 30 to December 26) of 2009 were retrieved and collected from electronic databases at 9 hospitals. Visitors 0-6, 7-12, 13-18, 19-29, 30-64, and 65years or more of age were classified into group I to VI, respectively. A total of 107,467visitors were seen at Flu-clinics for a 17-week study period. Of those, 32,485 were laboratory-confirmed. Antivirals were prescribed for 62,533 visitors. Numbers of visits, prescriptions of antivirals, and laboratory-confirmed cases of the pandemic influenza (H1N1 2009) peaked at Week 44. A large number of visits by group II and III were followed by those of group I and V, especially around the peak. Numbers of visits by group VI were lowest in all hospitals. In some hospitals, higher number of visits lasted longer in children than in adults while vice versa in other hospitals depending on the location. In summary, the pandemic influenza (H1N1 2009)was presumed to peak in late October and involved majorly children and students in Korea. Unique age distribution of visitors to flu clinic was observed in some hospitals.

참고문헌 (Reference)

1 이동한, "정부의 신종인플루엔자 A(H1N1) 대응" 대한예방의학회 43 (43): 99-104, 2010

2 김우주, "신종인플루엔자 A/H1N1 대유행: 현황과 전망" 대한의사협회 52 (52): 787-794, 2009

3 김우주, "신종인플루엔자 A (H1N1) 대유행의 전망과 대책" 대한내과학회 77 (77): 139-142, 2009

4 Centers for Disease Control and Prevention(CDC), "Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009" 58 : 585-589, 2009

5 Nishiura H, "Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan" 14 : 19227-, 2009

6 Centers for Disease Control and Prevention (CDC), "Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal inf luenza vaccine" 58 : 521-524, 2009

7 Korea Centers for Disease Control and Prevention, "Serologic cross-reactivity of serum samples from different age groups in Korea against a novel influenza A (H1N1) virus" 2 : 744-745, 2009

8 World Health Organization, "Preliminary information important for understanding the evolving situation : Pandemic (H1N1) 2009 briefing note 4"

9 Centers for Disease Control and Prevention (CDC), "Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009" 58 : 467-470, 2009

10 정희진, "Novel Influenza A (H1N1): Where Are We?" 대한의학회 24 (24): 361-362, 2009

11 Korea Centers for Disease Control and Prevention, "Influenza A (H1N1) 2009 vaccination program in Korea" 2 : 761-, 2009

12 Kim WJ, "Epidemiologic and clinical characteristics of pandemic influenza (1918~2009)" 14 (14): S121-S128, 2009

13 Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, "Emergence of a novel swine-origin influenza A (H1N1) virus in humans" 360 : 2605-2615, 2009

14 Korea Centers for Disease Control and Prevention, "Current status of selected infectious diseases" 2 : 886-, 2009

15 Korea Centers for Disease Control and Prevention, "Acute infectious agents laboratory surveillance reports (weekly): Week 52 of 2009"

16 Centers for Disease Control and Prevention (CDC), "2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009" 58 : 913-918, 2009